Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHEK1 | O14757 | 16/20 | 0.70 |
| ▸ | IKBKB | O14920 | 3/20 | 0.56 |
| ▸ | JAK2 | O60674 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | EIF2AK2 | P19525 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.56 |
| ▸ | JAK3 | P52333 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL490930 | 0.82 | CHEK1 (0.69) | CHEK1IKBKBJAK2MEN1EIF2AK2 | |
| SCHEMBL490632 | 0.82 | CHEK1 (0.69) | CHEK1IKBKBJAK2MEN1EIF2AK2 | |
| SCHEMBL490619 | 0.81 | CHEK1 (0.70) | CHEK1IKBKBJAK2MEN1EIF2AK2 | |
| SCHEMBL491021 | 0.81 | CHEK1 (0.70) | CHEK1IKBKBJAK2MEN1EIF2AK2 | |
| SCHEMBL4093829 | 0.81 | CHEK1 (1.00) | CHEK1IKBKBJAK2MEN1EIF2AK2 | |
| SCHEMBL2970675 | 0.81 | CHEK1 (0.63) | CHEK1IKBKBJAK2MEN1EIF2AK2 | |
| SCHEMBL3612892 | 0.81 | CHEK1 (0.66) | CHEK1IKBKBJAK2MEN1EIF2AK2 | |
| SCHEMBL1929626 | 0.80 | CHEK1 (1.00) | CHEK1IKBKBJAK2MEN1EIF2AK2 | |
| SCHEMBL1382705 | 0.79 | IKBKB (0.69) | CHEK1IKBKBJAK2MEN1EIF2AK2 | |
| SCHEMBL4087425 | 0.79 | CHEK1 (0.80) | CHEK1IKBKBJAK2MEN1EIF2AK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1421074-B1 | NOVEL COMPOUNDS | ASTRAZENECA AB (SE) | 2010-09-29 | — | — | EP | disclosed |